These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38259671)

  • 1. Study of miRNA and lymphocyte subsets as potential biomarkers for the diagnosis and prognosis of gastric cancer.
    Li J; Chen Z; Li Q; Liu R; Zheng J; Gu Q; Xiang F; Li X; Zhang M; Kang X; Wu R
    PeerJ; 2024; 12():e16660. PubMed ID: 38259671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrophic gastritis and gastric cancer tissue miRNome analysis reveals hsa-miR-129-1 and hsa-miR-196a as potential early diagnostic biomarkers.
    Varkalaite G; Vaitkeviciute E; Inciuraite R; Salteniene V; Juzenas S; Petkevicius V; Gudaityte R; Mickevicius A; Link A; Kupcinskas L; Leja M; Kupcinskas J; Skieceviciene J
    World J Gastroenterol; 2022 Feb; 28(6):653-663. PubMed ID: 35317427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ascites-derived hsa-miR-181a-5p serves as a prognostic marker for gastric cancer-associated malignant ascites.
    Yang Y; Zhang J
    BMC Genomics; 2024 Jun; 25(1):628. PubMed ID: 38914980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
    BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
    Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
    Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR 21-5p as a predictor of recurrence in young gastric cancer patients.
    Park SK; Park YS; Ahn JY; Do EJ; Kim D; Kim JE; Jung K; Byeon JS; Ye BD; Yang DH; Park SH; Hwang SW; Jung HY; Myung SJ
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1429-35. PubMed ID: 26824898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential miRNA-target interactions for the screening of gastric carcinoma development in gastric adenoma/dysplasia.
    Kim YJ; Hwang KC; Kim SW; Lee YC
    Int J Med Sci; 2018; 15(6):610-616. PubMed ID: 29725252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA hsa_circ_0001829 promotes gastric cancer progression through miR-155-5p/SMAD2 axis.
    Niu Q; Dong Z; Liang M; Luo Y; Lin H; Lin M; Zhong X; Yao W; Weng J; Zhou X
    J Exp Clin Cancer Res; 2020 Dec; 39(1):280. PubMed ID: 33308284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlation of circulating pro-angiogenic miRNAs' expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer.
    Peng W; Liu YN; Zhu SQ; Li WQ; Guo FC
    Cancer Med; 2018 Aug; 7(8):3773-3791. PubMed ID: 30003708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNAs as potential biomarkers for the progression of gastric cancer inhibit CREBZF and regulate migration of gastric adenocarcinoma cells.
    Kim YJ; Jeong S; Jung WY; Choi JW; Hwang KC; Kim SW; Lee YC
    Int J Med Sci; 2020; 17(6):693-701. PubMed ID: 32218690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripherical Blood hsa-miR-335-5p Quantification as a Prognostic, but Not Diagnostic, Marker of Gastric Cancer.
    Ramírez-Vidal L; Becerril-Rico J; Monroy-Mora A; Tinajero-Rodríguez JM; Centeno-Cruz F; Oñate-Ocaña LF; Ortiz-Sánchez E
    Diagnostics (Basel); 2024 Jul; 14(15):. PubMed ID: 39125490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
    Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
    Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
    Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
    Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum MiRNA panel as potential biomarkers for chronic hepatitis B with persistently normal alanine aminotransferase.
    Tan Y; Ge G; Pan T; Wen D; Gan J
    Clin Chim Acta; 2015 Dec; 451(Pt B):232-9. PubMed ID: 26483130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of plasma miR-4505, miR-4743-5p and miR-4750-3p as novel diagnostic biomarkers for coronary artery disease in patients with type 2 diabetes mellitus: a case-control study.
    Szydełko J; Czop M; Petniak A; Lenart-Lipińska M; Kocki J; Zapolski T; Matyjaszek-Matuszek B
    Cardiovasc Diabetol; 2024 Jul; 23(1):278. PubMed ID: 39080630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a necroptosis-related prognostic model for uterine corpus endometrial carcinoma.
    Zhang Q; Luo Y; Zhang S; Huang Q; Liu G
    Sci Rep; 2024 Feb; 14(1):4257. PubMed ID: 38383747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis.
    Zheng L; Wang J; Jiang H; Dong H
    Dis Markers; 2022; 2022():3391878. PubMed ID: 35371342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients.
    Ghaedi H; Mozaffari MAN; Salehi Z; Ghasemi H; Zadian SS; Alipoor S; Hadianpour S; Alipoor B
    Gene; 2019 Mar; 687():135-142. PubMed ID: 30447342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation.
    Qu K; Zhang X; Lin T; Liu T; Wang Z; Liu S; Zhou L; Wei J; Chang H; Li K; Wang Z; Liu C; Wu Z
    Sci Rep; 2017 May; 7(1):1692. PubMed ID: 28490741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.